January 13, 2021
As the Ohio Department of Health’s phased approach to vaccination moves from Phase 1A to Phase 1B, the vaccine will be offered to a broader cross-section of the community beginning the week of Jan. 19.
January 11, 2021
The antigen-based tests, performed in partnership with The University of Toledo Medical Center and collected via a shallow nasal swab, will provide results in approximately 30 minutes.
January 11, 2021
Lindsay Bowman, left, owner of LBs Circuit Training, and members of the gym raised donations to provide bags with natural cleaning products, snacks and gas cards for radiation and infusion patients at Eleanor N. Dana Cancer Center at The University of Toledo Medical Center.
January 7, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials. Read: UTMC patients part of national study on COVID drugs
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about hospital’s participation in a nationwide NIH study aimed at quickly and efficiently identifying additional therapeutics for COVID-19 worthy of larger clinical trials.
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the importance of developing new COVID-19 therapies and how UTMC is playing a role by participating in a nationwide NIH study of experimental treatments.
January 5, 2021
The proof-of-concept study is intended to quickly screen out ineffective experimental treatments while rapidly advancing the deployment of therapeutics that show significant benefit to hospitalized COVID-19 patients.
January 5, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, discusses how UTMC has begun recruiting patients to participate in an NIH study seeking to identify which coronavirus treatments are most effective and deserve more attention in clinical trials. Read: UTMC begins participation in national coronavirus treatment study
January 3, 2021
UToledo Interim President Gregory Postel and UTMC CEO Rick Swaine discuss momentum at the hospital and plans for 2021. Read: UTMC looks to emerge from dark year
December 25, 2020
UTMC CEO Rick Swaine discusses the partnership between UTMC and Toledo Clinic. Read: Renewed optimism: UTMC-Toledo Clinic partnership finds early success
